How can we manage our own health better? Does where you come from affect your reactions to certain drugs? Garth, Angela, and Eric talk about getting real-world research and help guide Phase III studies in the medical field.
Data, especially in the medical arena, has the power to be both empowering or overwhelming. How do we use data moving forward to not only make a positive change, but help guide a conversation? How do we make those data choices that can give the greatest benefit to the most people?
Getting the right content to the right audience is the basis of all communication. But in the healthcare industry, there are so many messages, it’s easy to be confused and send messages to the wrong consumer. This can lead to future issues for both the physician and patient. How do we build trust to make sure messages are delivered to the right people?
Using social networks to better engage with patients in big pharma can not only give voice to the patient perspective, it can also generate data that helps change the way organizations engage with their most important customers.
What if talking to patients, (the very thing clinicians and big pharma want to avoid at all costs), was actually a good thing?
Can we truly help patients make informed choices about their health when they may not fully comprehend the information we are sharing with them? Is there a better way to creatively engage customers that isn’t an approvable but ultimately soul-sucking storytelling experience?
No, this isn’t the intro to an insufferable marketing joke—this really happened. The creative ideas that came back (from real, live creatives) was more diverse and prolific than a traditional brief. Bad news for planners. Traditional creatives will be relieved to know the AI work against the brief was unusable. Good news for creatives.
Is pharma waking up to the idea that putting patients at the center of everything they do is a powerful way to improve healthcare from clinical trial to creation of the label, and all the way through to therapies that encourage compliance?
Gene therapy offers tremendous opportunity for a cure, but can big pharma take advantage? Can they move quickly enough for customers who are counting on them? Will the disruptors coming out of health tech beat them to it?
The challenge with current healthcare apps is that they are typically very narrow. They don’t reflect the broader community that the patient engages with. And more practically, the data generated goes into a black hole. What if they could see ALL of their data and personal medical information on demand anywhere they went?